{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:06:38Z","timestamp":1790917598758,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.actatropica.2004.11.009","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T16:52:35Z","timestamp":1110559955000},"page":"41-47","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"94","author":[{"given":"Suman","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.L.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2004.11.009_bib1","first-page":"541","article-title":"AIDS and L. infantum: new approaches for a new epidemiological problem","volume":"14","author":"Alvar","year":"1996","journal-title":"Clin. Parasitol."},{"key":"10.1016\/j.actatropica.2004.11.009_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/170.2.413","article-title":"Recombinant human granolocyte macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis","volume":"170","author":"Badaro","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2004.11.009_bib3","first-page":"129","article-title":"Visceral leishmaniasis in patients infected with human immunodeficiency virus","volume":"111","author":"Berenguer","year":"1989","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2004.11.009_bib4","first-page":"257","article-title":"Chemotherapy of leishmaniasis","volume":"vol. 1","author":"Beveridge","year":"1963"},{"key":"10.1016\/j.actatropica.2004.11.009_bib5","first-page":"439","article-title":"Exploration of antileishmanial activity in heterocycles: results of their in vivo and in vitro bioevaluations","volume":"89","author":"Bhatnagar","year":"1989","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2004.11.009_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2004.11.009_bib7","first-page":"324","article-title":"Picroliv affects \u03b3-glutamyl cycle in liver and brain of Mastomys natalensis infection with Plasmodium berghei","volume":"32","author":"Chander","year":"1994","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.actatropica.2004.11.009_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2006-960009","article-title":"Picroliv afford protection against thioacetamide induced hepatic damage in rats","volume":"57","author":"Dwivedi","year":"1991","journal-title":"Plant Med."},{"key":"10.1016\/j.actatropica.2004.11.009_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0773.1992.tb00566.x","article-title":"Picroliv and its components kutkoside and Picroside I protect liver against galactosamine induced damage in rats","volume":"71","author":"Dwivedi","year":"1992","journal-title":"Pharmacol. Toxicol."},{"issue":"June issue","key":"10.1016\/j.actatropica.2004.11.009_bib10","first-page":"2","article-title":"Oral miltelfosine may revolutionize treatment of visceral leishmaniasis","volume":"68","author":"Ganguly","year":"2002","journal-title":"TDR News No."},{"key":"10.1016\/j.actatropica.2004.11.009_bib11","first-page":"456","article-title":"A rising trend in kala-azar in Varanasi district, Uttar Pradesh. India: a recent survey using direct agglutination test","volume":"73","author":"Gupta","year":"1997","journal-title":"Curr. Sci."},{"key":"10.1016\/j.actatropica.2004.11.009_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomized controlled trial of aminosidine (Paramomycin) V. Sodium stibogluconate for treating visceral leishmaniasis in north Bihar, India","volume":"ii","author":"Jha","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/j.actatropica.2004.11.009_bib13","first-page":"371","article-title":"Kala-azar epidemic in Varanasi district, India","volume":"77","author":"Kumar","year":"1999","journal-title":"Bull. WHO"},{"key":"10.1016\/j.actatropica.2004.11.009_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunochemotherapy for Leishmania donovani infection: \u03b3-interferon plus pentavalent antimony","volume":"157","author":"Murray","year":"1988","journal-title":"J. Infec. Dis."},{"key":"10.1016\/j.actatropica.2004.11.009_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-2006-961542","article-title":"Immunostimulant activity of picroliv, the irridoid glycoside fraction of Picrorhiza kurroa and its protective action against Leishmania donovani infections in hamsters","volume":"58","author":"Puri","year":"1992","journal-title":"Plant Med."},{"key":"10.1016\/j.actatropica.2004.11.009_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2006-957882","article-title":"Picroliv protects against alcohol induced chronic hepatotoxicity in rats","volume":"62","author":"Rastogi","year":"1996","journal-title":"Plant Med."},{"key":"10.1016\/j.actatropica.2004.11.009_bib17","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.44.6.1494-1498.2000","article-title":"Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis","volume":"44","author":"Smith","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2004.11.009_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00034989858998","article-title":"Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultrashort courses of amphotericin-B lipid complex","volume":"92","author":"Sundar","year":"1998","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2004.11.009_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034989958096","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"Sundar","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2004.11.009_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0035-9203(84)90131-7","article-title":"Epidemiological, clinical and therapeutic features of Bihar\u2014kala-azar (including post kala-azar dermal leishmanniasis)","volume":"78","author":"Thakur","year":"1984","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2004.11.009_bib21","unstructured":"World Health Organization, 1996. Inf. Circ. WHO Mediterr. Zoon Control. Cent. 40, 11"},{"key":"10.1016\/j.actatropica.2004.11.009_bib22","unstructured":"World Health Organization, 1998. Tropical Diseases Research Progress 1997\u20131998. Fourteenth Programme Report\u2014Leishmaniasis. pp. 1\u201322."},{"key":"10.1016\/j.actatropica.2004.11.009_bib23","unstructured":"World Health Organization, 1999. TDR\/WHO sponsored meeting on VL control, Varanasi, India. 12\u201314 (January)."},{"key":"10.1016\/j.actatropica.2004.11.009_bib24","unstructured":"World Health Organization, 2002. Special feature: miltefosine\u2014breakthrough new oral treatment for visceral leishmaniasis, no. 68 (June issue)"},{"key":"10.1016\/j.actatropica.2004.11.009_bib25","series-title":"Biostatistical Analysis","author":"Zar","year":"1999"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T06:20:28Z","timestamp":1548656428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X05000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0001706X05000343"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2004.11.009","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}